
iBio IBIO
$ 2.65
-1.49%
Quarterly report 2025-Q4
added 02-10-2026
iBio P/B Ratio 2011-2026 | IBIO
Annual P/B Ratio iBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.07 | 0.354 | 0.0115 | 0.349 | - | 5.19 | 5.31 | 0.539 | 3.1 | 2.09 | 4.14 | 4.03 | 4.87 | 7.56 | 424 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 424 | 0.0115 | 33.2 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Aptorum Group Limited
APM
|
0.347 | $ 0.82 | -3.48 % | $ 4.47 M | ||
|
Rigel Pharmaceuticals
RIGL
|
1.53 | $ 33.23 | -4.03 % | $ 584 M | ||
|
Graybug Vision
GRAY
|
0.242 | - | -11.23 % | $ 9.65 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Apellis Pharmaceuticals
APLS
|
7.49 | $ 20.15 | -2.68 % | $ 2.54 B | ||
|
AbCellera Biologics
ABCL
|
0.995 | $ 3.72 | -2.75 % | $ 1.11 B | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.14 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
98.2 | $ 163.7 | -1.61 % | $ 8.14 B | ||
|
BridgeBio Pharma
BBIO
|
-6.31 | $ 64.66 | -1.37 % | $ 12.4 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 8.52 | -2.46 % | $ 1.39 B | ||
|
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | ||
|
CymaBay Therapeutics
CBAY
|
11.7 | - | - | $ 3.45 B | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Avid Bioservices
CDMO
|
6.95 | - | - | $ 789 M | ||
|
Certara
CERT
|
1.01 | $ 7.16 | 1.49 % | $ 1.15 B | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
0.122 | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | ||
|
Capricor Therapeutics
CAPR
|
6.87 | $ 25.91 | -3.56 % | $ 694 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
3.19 | $ 24.0 | 0.5 % | $ 2.93 B | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
4.35 | $ 0.99 | -3.28 % | $ 72.7 M | ||
|
Corvus Pharmaceuticals
CRVS
|
2.43 | $ 17.75 | -0.79 % | $ 852 M | ||
|
CTI BioPharma Corp.
CTIC
|
-31.3 | - | - | $ 1.2 B | ||
|
CohBar
CWBR
|
0.346 | - | -15.44 % | $ 2.2 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-2.57 | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-50.3 | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.42 | - | - | $ 2.18 B | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Denali Therapeutics
DNLI
|
2.47 | $ 20.02 | -4.67 % | $ 3.29 B | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Eton Pharmaceuticals
ETON
|
7.39 | $ 17.54 | -3.36 % | $ 450 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
2.36 | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
-0.0624 | - | 7.55 % | $ 38.1 M |